Magnus Group is pleased to welcome you to join the forthcoming “2nd Edition of International Summit on Hematology and Blood Disorders” (Hematology 2025) which is scheduled as an Hybrid Event during March 20-22, 2025 at Madrid, Spain.
This Hybrid mode allows you to participate as in-person in Madrid, Spain or Virtual from your home or work.
The conference deliberations will be on the theme “Transfusing Innovations and Exploring Emerging Concepts in Hematology” and it amalgamates researchers, scientists, academicians, healthcare professionals, hematologists, transfusion experts, physicians, nurses, practitioners, clinicians, industry representatives and individuals who are fascinated in sharing their plethora of knowledge and research in all aspects related to haematology and blood disorders whilst highlighting the best practices from different verticals in this field.
The congress will be structured around a series of keynotes sessions, symposiums, workshops, oral and poster presentations in which delegates will have the opportunity to network with and learn from leaders in the academic and corporate medical imaging and clinical research communities throughout the world. The scientific gathering provides an incredible opportunity to a vast array of individuals from the Hematology community to combat the concerns that surround the blood disorders.
Hematological abnormalities are thought to play a role in COVID-19 disease progression. However, the precise relationships between certain blood markers and COVID-19 are unknown. The conference also aims to assess if there are any links between haematological markers and the severity of COVID-19.
We are anticipating a highly thriving and open community in which you will join us and find Hematology 2025 quite engaging and promising for future developments.